News
📈 Stocks
Vaxcyte CEO Sells 6,289 Shares for Taxes as Phase 3 Data Approaches
(63 days ago)
Vaxcyte CEO Grant Pickering offloaded shares for tax purposes, leaving investors focused on the upcoming Q4 readout of the VAX-31 trial, which…